Coagulation parameters in HIV
Completed
- Conditions
- HIV, thrombophilia
- Registration Number
- NL-OMON20034
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 39
Inclusion Criteria
Inclusion in the original INF-BEAST study
Exclusion Criteria
Declining informed consent to participate in the INF-BEAST2 study
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma levels of following markers:<br>- FVIII <br>- Anti-thrombin<br>- Protein C antigen<br>- Protein S antigen<br>- Free protein S<br>- Fibrinogen<br>- Lupus anticoagulans<br>- Von Willebrand factor<br>- D-dimer
- Secondary Outcome Measures
Name Time Method - Lipid plasma levels (including cholesterol, HDL- and LDL cholesterol and triglycerides)<br>- The occurrence of cardiovascular events (including myocardial infarction, cerebrovascular accidents, peripheral arterial disease, arterial thrombosis) and venous thrombosis at any site